• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
EDUCATION
 

EDUCATION

on

  • 1,721 views

 

Statistics

Views

Total Views
1,721
Views on SlideShare
1,721
Embed Views
0

Actions

Likes
0
Downloads
5
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft Word

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    EDUCATION EDUCATION Document Transcript

    • CURRICULUM VITAE NAME : SHAH URMIL GIRISHBHAI, MD, DM (Cardiology) CONTACT DETAILS: Office: Care Institute of Medical Sciences Nr. Shukan Mall Off Science City Road, Sola Ahmedabad- 380060, Gujarat, India Mobile: +91-9825066939 (Personal) +91-9825066664, 9825066668 Residence: B-21, Aryamaan Bunglows, Thaltej-Shilaj Road Ahmedabad 380054, Gujarat India. Ph No. 07932520402 Email drurmilg@hotmail.com urmil.shah@heartcareclinic.org urmil.shah@cims.me Website www.indianheart.com DATE OF BIRTH : 25th September 1967. NATIONALITY : Indian. NATIVE PLACE : Ahmedabad. SEX : Male. MARITAL STATUS : Married. Name of Wife : Dr. Manisha Shah M.D (Pathology) Children : Two 1. kaivaan Shah (Male) Age- 11 (as in 2010) 2. Manvi Shah (Female) Age- 7 (as in 2010)
    • EDUCATION Pre-university : Passed Higher Secondary Examination in 1984. University Examination: Studied in Faculty of Medicine. M.B.B.S. M. D. (Internal Medicine) D. M. (Cardiology) Exams University Passed In marks obtained/ Attempt Year out of First Gujarat University Feb. 1986. 435/750 First M.B.B.S. Ahmedabad. Second Gujarat University Nov. 1987. 367/600 First M.B.B.S. Ahmedabad. Third Gujarat University May 1989. 608/1000 First M.B.B.S. Ahmedabad. M.D. Gujarat University April 1993. 507/1000 First (Int. Med.) Ahmedabad. D.M. Gujarat University Sep. 1996. 525/1000 Second (Cardiology) Ahmedabad. MEDICAL COUNCIL No.G.18727; 2nd August 1990. REGISTRATION Additional No: 5586, 31st may 1993. EXPERIENCE: 1. Rotating Internship from 07.07.1989 to 06.07.1990 (One year) 2. Resident in Medicine Department, Civil Hospital, Ahmedabad, 380016. Out of these three years of residency, specialized training in various departments like Cardiology, Nephrology, Cancer, Gastro-enterology, and Emergency medicine. This intensive training in General Medicine and related specialities included emergency medicine, and involvement in regular teaching of under-graduate students. EXPERIENCE (After M.D. Degree)
    • ALL TEACHING INSTITUTIONS-UNIVERSITY HOSPITALS Post Department Hospital/Teaching Period Duration Institution Senior Cardiology U.N.Mehta Heart 27.01.94 2 yrs Resident Department Hospital to Civil Hospital 26.01.96 Research Cardiology Institute of Cardiology 14.04.96 1 & 1/2 Fellow Department and Research Center, to Yrs B. J. Medical College, 16 09 97 Ahmedabad. Assistant Cardiology Institute of Cardiology 16 9 1997 Professor Department and Research Center, to 4 yrs B.J. Medical College, 23 07 2001 Ahmedabad. Current Consultant Krishna Heart from 1st March 2004 till today Affiliation Cardiologist Institute, SAL Hospital, Sterling Hospital Apollo Hospital, Formerly affiliated to V.S. General Hospital The experience as a Senior Resident in Cardiology entailed extensive training in:  Clinical Cardiology, with case study and management of all varieties of patients with Cardiac ailments.  All routine non-invasive cardiac investigation including exercise stress testing, Holter monitoring and echocardiography with color Doppler imaging.  Cath. Lab procedures including cardiac catheterization angiography, coronary angiography, pacemaker, valvuloplasty, peripheral and coronary angioplasty and other related invasive therapeutic interventions. Thus also entails active participation in temporary and permanent cardiac pacemaker implantations.  All bedside invasive procedures including pericardiocentesis, temporary cardiac pacing, and hemodynamic monitoring during ICCU care.  Routine pre-operative evaluation and active involvement in peri-operative management of all closed and open-heart surgical patients.  Regular teaching of undergraduate and postgraduate students in different aspects of clinical cardiology.
    • PRACTICAL PROCEDURES PERFORMED: Involved in more than 30000 cardiac catheterization and angiography procedures. This includes:  Coronary angiography. (>20000)  Pediatric cardiac catheterization. (>1500)  Valvuloplasties including balloon, mitral, aortic and pulmonary valve dilatation. (>2000)  Peripheral angioplasties including renal angioplasties and carotid stenting (>100)  Coronary intervention. PTCA (>3000) Stents (>2000) PAMI (>500) Directional Atherectomy. (>15) Rotational Atherectomy (>10) Graft vessel intervention with filter device (>10)  ASD Device >5  PDA coil Closure >75  PDA Amplatzer device >40  Balloon dilatation and stenting of Coarctation of Aorta  Permanent pacemaker implantation including Dual Chamber Pacing > 100 NONINVASIVE PROCEDURE Color Doppler echocardiography >25000 Pediatric Echocardiography > 4000 Trans Esophageal Echocardiography >100 Dobutamine Echocardiography >200 Intra-operative Echocardiography >50 Stress test > 2500 Holter test >250 Head Tilt table test >50
    • RESEARCH EXPERIENCE/SCIENTIFIC PUBLICATIONS:  Thesis/Dissertation submitted to Gujarat University for the degree of M.D. (General Medicine) in 193. “Clinical Profile of Mediastinal Mass”.  Thesis/Dissertation submitted to Gujarat University for degree of D.M. (Cardiology) in 1995. “Immediate and short term outcome of patients undergoing PTCA – a study of 232 lesions in 200 patients. 1. Dani S I, Chag M C, Patel T M, Shah S C, Shah U G, Thakore S B, Patel T K : PTMC for juvenile rheumatic mitral stenosis. Ind Heart J : 47: 6 : 79; 1995(abstract). 2. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Thomas V M, Patel T K : How to minimise radiation to foetus during balloon mitral valvuloplasty in pregnant women. Ind Heart J : 47: 6 : 80; 1995(abstract). 3. Chag M C, Patel T M, Dani S I, Thomas V M, Shah U G, Jain S, Patel T K : Balloon aortic valvuloplasty for severe aortic stenosis. Ind Heart J : 47: 6 : 163; 1995(abstract). 4. Chag M C, Dani S I, Patel T M, Shah S C, Shah U G, Thomas V M, Patel T K : Balloon angioplasty for native coarctation of aorta beyond infancy. Ind Heart J : 47: 6 : 164; 1995(abstract). 5. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Thakore S B, Rawal J R, Patel T K : Technical challenges in PTCA with reused hardware. Ind Heart J : 47: 6 : 219; 1995(abstract). 6. Patel T M, Dani S I, Chag M C, Shah S C, Shah U G, Patel T K : Crossing of mitral orifice with the Inoue balloon : the straight balloon technique. Cathet Cardiovasc Diagn 37 : 231-232, 1996. 7. Dani S I, Patel T M, Rawal J R, Shah S C, Shah U G, Jain S, Patel T K : Elective primary stenting for complex coronary lesions : clinical and angiographic follow up. Ind Heart J : 48: 5 : 164; 1996(abstract). 8. Patel T M, Dani S I, Rawal J R, Shah U G, Thomas V M, Baxi H, Patel T K : Balloon mitral and aortic valvuloplasty in mirror-image dextrocardia. Ind Heart J : 48: 5 : 240; 1996(abstract). 9. Patel T M, Dani S I, Chag M C, Thakore S B, Shah S C, Shah U G, Patel T K : Balloon mitral and aortic valvuloplasty in mirror image dextrocardia. J Invas Cardiol 8 : 164-168, 1996. 10. Patel T M, Dani S I, Shah S C, Shah U G, Patel T K : Balloon pulmonary valvuloplasty using the Inoue catheter : A novel 'free-float' Inoue technique. J Invas Cardiol, Oct.1996. 11. Balloon Mitral Valvuloplasty in Calcific Mitral Stenosis : Immediate and Mid Term Results : Bhupesh Shah, Sameer Dani, Jayesh Rawal, Urmil Shah, Vipin Thomas, Sharad Jain. Institute of Cardiology and Research Centre, Ahmedabad. Indian Heart J 1997 ; 49 : 629. IHJ, Nov-Dec. 1997. 12. Multitrack System for Balloon Mitral Valvuloplasty : Initial Results : Jayesh Rawal, Sameer Dani, Bhupesh Shah, Urmil Shah, Institute of Cardiology and Research Centre,Ahmedabad.Indian Heart J 1997 ; 49 : 630. IHJ, Nov-Dec. 1997. 13. Concurrent Multivalvular Balloon Dilatation : Acute Results and Short Term Follow-up : Urmil Shah, Sameer Dani, Bhupesh Shah, Jayesh Rawal, Sharad Jain, Jayesh Prajapati, Anish Chandarana, Hasit Joshi, Institute of Cardiology and Research Centre, Ahmedabad.Indian Heart J 1997 ; 49 : 633. IHJ, Nov-Dec. 1997. 14. Pura Vario - A Poor Man's Stent : Six Months Clinical and Angiographic Follow - up : DR Solanki, SI Dani, BR Shah, UG Shah, SR Jain, J Prajapati, A Chandarana. UN Mehta Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad. Indian Heart J 1998 ; 50 : 639. IHJ, Nov-Dec. 1998.
    • 15. Intracoronary "Saint Come" Stents : Short and Mid-Term Follow-up Results : BR Shah, SI Dani, UG Shah, SR Jain, DR Solanki, H Baxi, A Chandarana. Department of Cardiology, UN Mehta Institute of Cardiology and Research Centre, Civil Hospital,Ahmedabad.Indian Heart J 1998 ; 50 : 639. IHJ, Nov-Dec. 1998. 16. Non-Surgical Mitral Commissurotomy Using A New Metallic Dilator : SI Dani, SR Jain, BR Shah, UG Shah, J Prajapati, DR Solanki, H Joshi, UN Mehta Institute of Cardiology and Research Centre, Civil Hospital, Ahmedabad.Indian Heart J 1998 ; 50 : 645. IHJ, Nov-Dec. 1998. 17. Combination of Plain PTCA with Stenting in Coronary Artery Disease : Immediate and Intermediate - Term Outcome. SI Dani, BR Shah, UG Shah, SR Jain, H Baxi, A. Chandarana UN Mehta Institute Of Cardiology and Reserch center , Civil Hospital, Ahmedabad . Indian Heart Journal 1998; 50 : 663. IHJ , Nov-Dec. 1998. 18. Retrieval Of Foreign Material From Vascular System: An Appraisal of arious retrival devices:SI Dani, DR Solanki, BR Shah , UG Shah , SR Jain, H baxi ,H. Joshi UN Mehta Institute of Cardiology and Reserch Center,Civil Hospital Ahmedabad .Indian Heart Journal 1998; 50 : 675. IHJ , Nov – Dec 1998 19. Ballloon Dilatation of Coarctation of Aorta in adults: Immediate and Folllow Up ;SI Dani , BR Shah,UG Shah. DR Solanki, J Prajapati , A Chandarana UN Mehta Institute of Cardiology and Reserch Center.Ahmedabad. Indian Heart Journal 1998 ; 50 : 691. IHJ Nov – Dec 1998 20. Left Main Coronary Artery disease in Gujarati Population., SI Dani , Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 jan 1998; Ahmedabad, Gujarat. 21. Immediate and Short Term Outcome of Patient Undergoing Plain PTCA SI Dani , Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 jan 1998; Ahmedabad, Gujarat. 22. Stent Implantation in Coronary Artery Disease: Acute and Mid Term Results SI Dani , Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 jan 1998; Ahmedabad, Gujarat. 23. Pulmonary Stenosis : Long term Results of Balloon Dilation SI Dani , Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 jan 1998; Ahmedabad, Gujarat. 24. Balloon Dilatation of Coarctation of AORTA: Immediate results and Intermediate Follow Up SI Dani , Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 jan 1998; Ahmedabad, Gujarat. 25. Permanent Pacemaker Implatation In Gujarat: A Single Center Experience SI Dani, Jayesh Rawal Bhupesh Shah, Urmil Shah,Sharad Jain, Jayesh Prajapati , Hemang Baxi, Anish Candarana, Hasit Joshi . Paper Presented in 19 APGCON 3-4 Jan 1998; Ahmedabad, Gujarat. 26. Comparision of Intravenous nicorandil with Intravenous Nitroglycerine in Patients with Unstable Angina .UG Shah , S Jain , P Jethavani , S Thanvi , BR shah, SI Dani UN Mehta Institute of Cardiology and Reserch Center ,civil Hospital Ahmedabad. Indian Heart Journal 1999 ; 51 : 704 . IHJ Dec 1999 27. Economical Consideration in Percutaneous Dilatation of Mitral Valve by Different Device and Hardware JR Rawal , UG Shah, JS Prajapati , BR Shah, AH Chandarana , SI Dani UN Mehta Institute of Cardiology and Research Center , Civil Hospital Ahmedabad. Indian Heart Journal 1999 ; 51: 723. IHJ Dec 1999
    • 28. Five Year Follow up after Inoue Balloon Mitral Valvuloplasty in Juveniles . JR Rawal, JS Prajapati, UG Shah , S Jain, SI Dani UN Mehta Institute of Cardiology and Research Center, Civil Hospital, Ahmedabad. Indian Heart Journal 1999; 51 732. IHJ Dec 1999 29. B.C. Kaji, G.R. Bhagat. Shah U.G. A study of 66 cases of mediastinal mass. Indian Journal of Internal Medicine,1993,No-8-10,248-253. 30. Dani S.I. Patel T.M., Chag M.C., Thakore S.B., Shah U.G., Patel T.K., Balloon Valvulopasty in adult pulmonary stenosis. Indian Heart Journal 1994, Vol.46, No.5,252(abstract). 31. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004 32. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004 33. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004 34. Chag M.C., Shah H. D., Parikh K.H., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Increased Lipoprotein (a) as a strong risk factor for Coronary Artery Disease and the effect of Niacin amongst Indians. European Society of Cardiology (Submitted) 2004. 35. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004. 36. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004. 37. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. European Society of Cardiology (Submitted) 2004. 38. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of combination of statins and fenofibrate with acute coronary syndrome undergoing Percutaneous Coronary Interventions. European Society of Cardiology (Submitted) 2004. 39. Chag MC, Shah HD, Joshi MV, Parikh KH, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Goyal RK. Renal artery stenting is safe and effective modality of treatment on mid term follow up. 2004 40. Shah HD, Iyer S, Shah K, Parikh K, Chag M, Shah UG, Baxi H, Chandarana A, Naik A, Goyal RK. Effect of Statins in combination with fenofibrate in patients after percutaneous transluminal coronary angioplasty,2004
    • 41. Mehta K N, Parikh K H, Chag MC, Shah U G, Baxi H A, Chandarana A H, Naik A M, Goyal R K, Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study,2005 42. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK, Association of White Blood cell count with the Occurrence of slow/no reflow in acute coronary Syndrome patients undergoing PCI.2005 43. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Patel GT, Mathan G, Shah JN, Goyal RK, Efficacy of Percusurge Guardwire system in acute Myocardial patients undergoing Primary/rescue PCI.2005 44. Kanan Shah, Keyur Parikh, Milan Chag, Urmil Shah, Anish Chandarana, Hemang Baxi, Ajay Naik, Ramesh K. Goyal, Avigilance study of distal protection device used during Percutaneous coronary interventions. 2006 45. KH Parikh, HA Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, MP Tanna, MC Chag, Initial Clinical experience with Bivalirudin as an anticoagulant during percutaneous coronary interventions in Asian Indian patients,2006 46. KH Parikh, HA Shah, JN Shah, UG Shah, HA Baxi, AH Chandarana, AM Naik, RK Goyal, MC Chag, Prospective randomized study of PercuSurge in Acute Myocardial Infarction Patients undergoing Revascularization with a special Emphasis on Procedural Time: A Two Year Follow-up. 2006 47. Chandarana AH, Shah JN, Shah HA, Shah UG, Baxi HA, Naik AM, Joshi M, Goyal RK, Parikh KH, Chag MC. High Prevalence Of Renal Artery Stenosis In Hypertensive Patients With Triple Vessel Coronary Artery Disease: Recommendation For Simultaneous Renal Arteriogram For Earlier Intervention.2006 48. HA Shah, JN Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, AM Naik, KH Parikh, RK Goyal. Association between the White Blood Cell Count and Occurrence of Slow or No Reflow Phenomenon in Patients with Acute Coronary Syndromes in the coronary Interventional Era,2006 49. HA Shah, MC Chag, MP Tanna, UG Shah, HA Baxi, AH Chandarana, AM Naik, JN Shah, KH Parikh. Incidences and Clinical Characteristics of No Reflow after Percutaneous Coronary Interventions in High Risk Asian Indian Patients. 2006 50. K. Parikh, AM Naik, HA Shah, AH Chandarana, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai, First In Man: Direct Comparison Of Conventional Coronary Sinus Angiography And CT Angiography For Visualization And Sizing Of Coronary Sinus,2006 51. K. Parikh, HA Shah, AH Chandarana, AM Naik, MC Chag, UG Shah, HA Baxi, JN Shah, A Medina, S Banai, First In Man: Multislice CT Angiography Visualization Of An Innovative First-in-man Coronary Sinus Reducer Stent In Patients With Refractory Angina,2006 52. K. Parikh, HA. Shah, AM. Naik, HA. Baxi, MC. Chag, UG. Shah, A. Hjalmarson, Y. Rozenman, First in Man: non invasive measurement of variation in Pulmonary artery pressure following exercise in heart failure patients using an innovative implantable device involving acoustic telemetry,2006 53. MC. Chag, HA. Shah, AM. Naik, HA. Baxi, UG. Shah, AH. Chandarana, Y. Rozenman, KH. Parikh, First-In-Man: Comparison of impressure device measuring pulmonary artery pressure non-invasively with conventional contrast echocardiography In Congestive Heart Failure,2006
    • 54. Parikh KH, shah HP, Naik AM, Chag MC, Shah UG, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y, First in man: Papirus-monitoring Pulmonary artery Pressure by Implantable device Responsible to Ultrasonic signals.2006 55. Parikh KH, shah HP, Naik AM, Chag MC, Shah UG,Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. Effect of Metoprolol XL on pulmonary artery pressure in patients with heart failure measured using first in human implantable Device responding to ultrasonic signal. 2006 56. Parikh KH, Shah HD, Naik AM, Chag MC, Shah UG, Baxi HA, Chandarana AH, Shah JN, Waagstein F, H Jalmanson A, Razenman Y. Effect of Metaprolol XL on Diurnal variation in pulmonary arterial pressure in Heart failure patients using first-in-man implantable device responding to ultrasonic signals,2006 57. Hetal A Shah, Ajay M Naik, Hemang A Baxi, Milan C Chag, Urmil G Shah, Anish H Chandarana 2, Ramesh K. Goyal, Yoseph Rozenman, Keyur H Parikh, First-in-man: effect of Metoprolol CR/XL uptitration on pulmonary artery pressure and its variation in chronic heart failure monitored non-invasively by an implanted device using ultrasonic signals 2007 58. Parikh KH, Chag MC, Shah KJ, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah HD, Goyal RK,2007 59. Shah HD, Parikh KH, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Shah JN, Shah KJ, Iyer S, Goyal RK, Beneficial Effects Of Addition Of Fenofibrate To Statin Therapy In Patients with Acute Coronary Syndrome After Percutaneous Coronary Interventions,2007 60. Parikh KH, Shah HA, Chag MC, Shah UG, Baxi HA, Chandarana AH, Naik AM, Goyal RK, Rozenman Y, Hjalmarson A, Effect of Metoprolol CR/XL on Pulmonary Artery Pressure in Chronic Heart Failure Patients Assessed by an Implanted Ultrasonic Device with Special Emphasis on Diurnal Variation and Exercise Capacity,2009 61. Keyur Parikh, Ashok Seth, Hemang Baxi, Anish Chandarana, Satya Gupta, Urmil Shah, Milan Chag, Sandhya Nair, Praveen Chandra, First In Man Assessment of Orbital Atherectomy System in Treating De Novo Calcified Coronary Lesions (ORBIT I),2009 62. Keyur Parikh, Milan Chag, Urmil Shah, Hemang Baxi, Anish Chanadarana, Ajay Naik, Satya Gupta, Shmuel Banai, Long Term Safety, Angina Relief and Improvement in Quality of Life in Patients with Refractory Angina Treated with the Neovasc Coronary Sinus Reducer,2009
    • INTERNATIONAL CLINICAL TRIALS: 1 Co - Investigator for To evaluate Percusurge / Guardwire Distal Protection Device Trial RUBY registry (For (Presented by Dr. Aman, Switzerland) completed India) (2002) 2 Co - Investigator at Enoxaparin and Thrombolysis Reperfusion for Acute Trial Sterling Hospital for Myocardial Infarction Treatment Thrombolysis in completed Extract-TIMI 25 Myocardial Infarction –Study 25 Multicentre multi national Trial (2003) 3 Co - Investigator for To evaluate the efficacy and safety of fondaparinux versus Trial OASIS-5 Trial (2004) Enoxaparin in the acute treatment of unstable angina or completed non ST-segment elevation myocardial infarction acute coronary syndromes 4 Co - Investigator for To evaluate the efficacy and safety of fondaparinux sodium Trial OASIS-6 Trial (2004) versus control therapy and Glucose-Insulin-Potassium completed infusion versus control in broad range in patients with ST - segment elevation acute myocardial infarction 5 Co - Investigator for To evaluate the safety and efficacy of intravenous Remodulin® Trial TRUST Trial (2004) in patients( in India) With Pulmonary arterial hypertension (PAH) completed in 12-week 6 Co-Investigator for Dose ranging study to evaluate the safety and efficacy of Trial Paediatric Olmesartan medoxomil in children and adolescents with completed Hypertension Trial hypertension (2005) 7 Co - Investigator for Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Trial Hypercholesterol Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up completed study (NK-104-301) Titration ) in Patients with Primary Hypercholesterolemia at The Heart Care Or Combined Dyslipidemia Clinic (2005) 8 Co - Investigator for To evaluate the safety of the Neovasc Reducer™ in the treatment of Trial Ischemic Neovasc Reducer™ heart Disease (IHD), controlled narrowing of the coronary sinus completed Pilot Study, First in human: (2005) 9 Co - Investigator For Monitoring Pulmonary Artery Pressure by Implantable Trial PAPIRUS Trial: Pilot Device Responding to Ultrasonic Signal(REMON Device) completed Study, First in Human: Apollo Hospital (2005) 10 Co - Investigator for Flow improvement in patients with Acute Myocardial Infarction Trial Export study (2006) undergoing either conventional stenting or a strategy of primary completed aspiration followed by stenting using the Export® Aspiration Catheter: a Prospective, Randomized, Controlled Study 11 Co - Investigator for To Evaluate the ‘Real World’ Clinical Performance of the Trial E-five registry (for Medtronic Endeavor™ ABT-578 Eluting Coronary Stent System. completed India) (2006) 12 Co- Investigator for Randomized Evaluation of Long term anticoagulant therapy Trial RELY study (2006) comparing efficacy and safety of two blinded doses of completed dabigatran etexilate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation : prospective, multi-centre, Parallel group, non-inferiority trial.
    • 13. Co - Investigator for Open label, long-Term (1year) extension study of Pitavastatin 4 mg QD in Trial Hypercholesterolemi patients with Primary Hypercholesterolemia or combined completed a study (NK-104-307) Dyslipidemia at The Heart Care Clinic (2006) 14 Co - Investigator for The e-SELECT Registry : A Multicenter Post Marketing Trial e-SELECT Registry Survelliance completed (2007) 15 Co - Investigator for Early Glycoprotein Iib/IIIa Inhibition in Non-ST-segment Elevation Trial Early ACS trial Acute Coronary Syndrome: A Randomized, Placebo-Controlled completed (2007) Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS) 16 Co - Investigator for A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and safety Trial PLATO trial (2007). study of AZD6140 Compares with Clopidogrel for prevention ofcompleted Vascular Events in patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of PLATelet inhibition and Patient Outcomes.] 17 Co - Investigator for Randomized, multinational, double-blind study, comparing a high Trial OASIS- 7 trial (2007) loading dose regimen of Clopidogrel versus standard dose in completed patients with unstable angina or non-ST segment elevation myocardial infarction managed with an early invasive strategy 18 Co - Investigator for First in Man: A Feasibility study to evaluate safety and efficacy of Trial New Guidewire New Guidewire for Crossing Total Occlusions in Coronary Arteries completed (2007) 19 Co-Investigator for A Randomized, double blind, Placebo-Controlled, Multicenter, Trial Paediatric Parallel Study Assessing the Efficacy, Safety, and Dose completed Hypertension Trial, Response of Ramipril for the Treatment of Hypertension in The Heart Care Children and Adolescents Clinic, Ahmedabad (2007) 20 Co-Investigator for Apixaban for reduction in stroke and other thromboembolic events Follow- Aristotle Trial at The in atrial fibrillation: Active controlled randomized double blind ups Heart Care Clinic, parallel arm study to evaluate efficacy and safety of Apixaban in ongoing Ahmedabad (2007) subject with non valvular Atrial fibrillation 21 Co-Investigator for Multicenter, Randomized, double-blind – dummy, Parallel-group, Follow- Rocket Trial at The Non-inferiority Trial Comparing the Efficacy and Safety of Once- ups Heart Care Clinic, daily oral Rivaroxabab (BAY 59-7939) with Adjusted-dose oral ongoing Ahmedabad (2007) Warfarin for the prevention of Stroke and Non-central-nervous- system systemic embolism in Subjects with Non-valvular Atrial Fibrillation 22 Co - Investigator for Patient Related Outcomes with Endeavor versus Cypher stenting Follow- PROTECT Trial Trial: Prospective, multicenter, randomized, two-arm, open-label ups (2007) trial ongoing 23 Co - Investigator for A clinical trial comparing Cangrelor to Clopidogrel in subject who Follow- TMC-CAN-05-02 require Percutaneous Coronary Intervention ups (2007) ongoing 24 Co - Investigator for A clinical Trial comparing treatment with Cangrelor (in Follow- TMC-CAN-05-03 combination with usual care) to usual care in subjects who require ups (2008) Percutaneous Coronary Intervention ongoing 25 Co - Investigator for Evaluation of the anti-anginal efficacy Follow- CL (Ivabradine) at ups The Heart Care Clinic ongoing (2008)
    • 26 Co - Investigator for Randomized Dabigatran Etexilate dose finding study in patients Trial RE-DEEM at The with acute coronary syndromes post index Event with additional completed Heart Care Clinic risk factors for cardiovascular complications also receiving aspirin (2008) and clopidogrel: Multi-centre, prospective, placebo controlled, group dose escalation trial 27 Co-Investigator for A Multicenter, Randomized, parallel-group efficacy superiority Follow- Magellan Trial (2008) study in hospitalize medically ill patients comparing rivaroxaban ups with Enoxaparin ongoing 28 Co-Investigator for A multicenter, randomized, double-blind, assessor-blind, non- Trial Borealis Trial at The inferiority study comparing the efficacy and safety of once-weekly completed Heart Care Clinic subcutaneous biotinylated idraparinux (SSR126517E) with oral Ahmedabad (2008) adjusted-dose warfarin in the prevention of stroke and systemic thromboembolic events in patient with atrial fibrillation 29 Co - Investigator for FREEDOM UT –15C Studies (TDE-PH-302 and TDE-PH-304) Ongoing Freedom-PAH at The conducted by United Therapeutics. Heart Care Clinic 30 Co - Investigator for Pilot study to evaluate the safety & performance or the diamond Trial ORBIT – 1 back 360TM orbit Atherectomy system in treating de-NOVO completed calcified coronary lesions – orbit -1 31 Co-Investigator for CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized, Trial AVERROES at The Double-Blind, Parallel arm Study to Evaluate the Efficacy and completed Heart Care Clinic Safety of Apixaban in Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation 32 Co - Investigator for A Double-blind, Randomized, Placebo-controlled, Multicenter Ongoing Red-HF at The Heart Study to Assess the Efficacy and Safety of Darbepoetin alfa Care Clinic Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia – 20050222 Amendment 1. 33. Co - Investigator for A Phase II, double-blind, Randomized, Placebo-controlled study Trial TAK-442-202 at The of the safety and Efficacy of TAK-442 in subjects with Acute completed Heart Care Clinic Coronary Syndrome. 34. Co - Investigator for A Randomized, Double-Blind Placebo controlled study of the Trial EISAI-202 at The safety and tolerability of E5555 and its effect on clinical event and completed Heart Care Clinic biomarkers in patient with Non ST segment Elevation Acute Coronary Syndrome. 35 Co-Investigator for E- Evaluation of the Endeavor Resolute Zolarolumes-Eluting Follow-up Resolute at the Heart Coronary Stent System in a ‘Real World’ Patient Population. ongoing Care Clinic 36 Co - Investigator of Randomized, Double Blind, Placebo Controlled, Event Driven, Follow-up RIVAROXABAN at Multi Center Study To Evaluate The Efficacy And Safety Of ongoing The Heart Care Clinic Rivaroxaban In Subjects With Recent ACS. 37 Co - Investigator of A Phase 3, Multi Center, Randomized, Double Blind, Placebo Ongoing Pfizer PAH at The Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Heart Care Clinic Subjects With Pulmonary Arterial Hypertension. B1321001 38 Co - Investigator of A Phase 3, Multi Center, Open Label Study To Evaluate The Long Ongoing Pfizer PAH at The Term Safety Of Monotherapy Sitaxsentan Sodium And Heart Care Clinic Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension. B1321002 39 Co - Investigator of A Phase 3, Multi Center, Randomized, Double Blind, Efficacy And Ongoing Pfizer PAH at The Safety Study Of Monotherapy Sitaxsentan Sodium Versus Heart Care Clinic Combination Therapy With Sitaxsentan Sodium and Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension Who
    • B1321003 Have Completed Study B1321001. 40 Co - Investigator of A Clinical Outcome Study Of Darapladib Versus Placebo In Follow-up LPL STABILITY at Subjects With Chronic Coronary Heart Disease To Compare The ongoing The Heart Care Clinic Incidence Of Major Adverse Cardiovascular Event. (MACE) 41 Co - Investigator of A Prospective Study Evaluating The Safety Of Two Regimens Of Follow-up OASIS-8 at The Adjustive Intravenous UFH PCI In High Risk Patients With ongoing Heart Care Clinic UA/NSTEMI Initially Treated With Subcutaneous Fondaparinux And Referred For Early Coronary Angiography. 42 Co-Investigator of A Randomized, Double Blind, Multi Centric, Placebo Controlled, Follow-up STEM CELL Single Dose, Phase I/II Study Assessing The Safety And Efficacy ongoing Of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cell In Patients With ST Elevated Acute MI (STEMI) Patient. 44 Co - Investigator for A Randomized, Double Blind, Placebo Controlled, Multi Center Follow-up RUBY 1Trial at The and Parallel Group Study of the Safety, Tolerability, and Efficacy ongoing Heart Care Clinic of YM150 in combination with Standard Treatment in Secondary Ahmedabad (2010) Prevention of Ischemic Vascular Events in Subjects with Acute Coronary Syndromes. 45 Co - Investigator for A phase 3, multi center, placebo controlled, randomized, double blind, Follow-up AmarinTrial at The 12 week study with an open label extension to evaluate the efficacy ongoing Heart Care Clinic And safety of AMR101 in patients with fasting triglyceride levels Ahmedabad (2010) > 500 mg/dl and < 2000 mg/dl. 46 Co Investigator for South Asian Systolic Heart Failure Registry Ongoing SASHF RTrial at The Heart Care Clinic Ahmedabad (2008) 47 Co Investigator for TRAC HF: Ambulatory Monitoring Using External Physiological Ongoing TRAC HF Trial at The Sensors in Heart Failure Patients. Heart Care Clinic Ahmedabad (2009) NATIONAL CLINICAL TRIALS 1 Co - Investigator for To evaluate the efficacy and safety of BIVAFLO® as an Trial completed BIVAFLO Registy adjunctive therapy during PCI in moderate-high risk (2006) ACS patients with provisional GP IIb/IIIa inhibitors use. 2 Co - Investigator for The COREL C Registry : A multicentre Post marketing Survelliance Trial completed CORREL + C Trial for clinical and angiographic evaluation of Corel C stent (2006) 3 Principal Investigator for A randomized double blind controlled trial of the efficacy Trial completed POLYCAP Trial at VS And safety of POLYCAP Vs its components in subjects hospital With atleast one additional cardiovascular risk factor Ahmedabad(2007) 4 Co - Investigator for A phase III, open label, multicentric, parallel group, Trial completed ACUNOVA Trial Randomized study to evaluate the safety and efficacy of (2006-2007) Abciximab in Indian patients scheduled for Percutaneuos Coronary Intervention.
    • 5 Co - Investigator for (1) A randomized, double blind parallel group, prospective dose completed Trial ZYHI Trial at The Heart ranging Care Clinic Ahmedabad study of ZYH 1 with an open fenofibrate arm to evaluate the efficacy (2007) on dyslipidemia in patients without diabetes Protocol No. 2001 Ver: 01 (2) A randomized, double blind parallel group, prospective dose ranging study of ZYH1 with an open pioglitazone arm to evaluate the efficacy on dyslipidemia in patients with diabetes Protocol No. 2003 Ver: 02 (3) A randomized, double blind parallel group, prospective dose ranging study of ZYH 1 with an open pioglitazone arm to evaluate the efficacy on dyslipidemia in patients with impaired glucose test Protocol No.2004 Ver: 02 PAPER PRESENTATION:  Presented a paper on immediate and short term outcome of patients under going PTCA – study of first 23 Angioplasties of 232 lesion in first 200 patients in Gujarat- At CSI in 1998.  Presented paper on multi-valve dilatation of 30 patients- At CSI in 1999.  Presented a paper on Initial experience of stenting- At APG in Ahmedabad 2000  Presented a case in PTCA registry meeting in Cochin in March 2001. ATTENDING CONFERENCES: I have attended various National conferences like CSI National Conference-Jaipur 1995, Calcutta, Madras ECHO workshop- Delhi 1997. PTCA registry meeting- Cochin 2001. As well as International Conferences like Asia-Pacific Interventional Cardiology workshop at Madras in 1996. PCI Intervention course in Paris May 2001, Interventional Cardiology workshop at Singapore in Oct 2001. American College of Cardiology, meeting at Atlanta from 16th March to 20th March 2002. To update knowledge in fast advancing field of Cardiology. SPECIAL ACHIVEMENT: Awarded fellowship by Cleveland Clinic Foundation, Ohio, U.S.A as International Scholar in Interventional Cardiology Department especially for  Saphaneous vein graft intervention with protection device  Carotid intervention with filter devices  IVUS  ASD Amplatzer devices
    •  PFO device  Trans-esophageal Echocardiography  Intra-operative Echocardiography  Dobutamine Echocardiography  Septal artery ablation for HOCM  For period of one month from 15th Feb to 15th March 2002 OTHER INVOLVEMENTS • Joined rotary as charter member in 2001 in rotary club of ahmedabad airport • President in year 2003/ 2004 • Chairmen of cardiac awareness in 2004 / 2005 • Chairman of sport activity in 2005 2006 • Abhar function in 2008/ 2009 award giving ceremony in year • Vice Chairman of cardiac awareness 2009 1010 S • Attended Various dis conferences and assembly • Multiple Cardiac awareness program and cardiac free check up nad camp echo • Speaker for heart disease prevention in intercity meet hosted by patan club • Assistant Governor, Zone 4 district 3050, 2010-2011 CAREER INTENTIONS:  Teaching medical students has been a pleasant hobby to me ever since I joined residency in General Medicine in 1989.  I am interested in working in an academic institution and university hospital. I enjoy educational activities and participate actively in academic and research programs.  I have given lectures in various medical associations in Gujarat, Conducted various CME programs and organized a live Echocardiography workshop at Sterling Hospital for the first time of its kind in State of Gujarat.  As a part of Care Cardiology Consultants I also actively participate in CME Programs for General Practitioners every month.  I am an active member of Care Cardiology Consultants’ JOURNAL CLUB of PHYSICIANS (MD)’. We hold a meeting every month to discuss the latest Journal Articles. REFERENCE : 1. Dr. Keyur Parikh Chairman Care Institute of Medical Sciences Nr. Shukan Mall Off Science City Road, Sola Ahmedabad- 380060, Gujarat,